Allspring Global Investments Holdings LLC Decreases Stock Holdings in Solventum Co. (NYSE:SOLV)

Allspring Global Investments Holdings LLC lessened its holdings in Solventum Co. (NYSE:SOLV) by 48.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,087 shares of the company’s stock after selling 5,664 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Solventum were worth $401,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Modus Advisors LLC acquired a new stake in shares of Solventum in the fourth quarter worth $25,000. Stonebridge Financial Group LLC acquired a new stake in shares of Solventum during the fourth quarter worth $26,000. Crews Bank & Trust acquired a new stake in shares of Solventum during the fourth quarter worth $32,000. True Wealth Design LLC increased its holdings in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after acquiring an additional 471 shares during the period. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Solventum in the 3rd quarter worth about $35,000.

Analyst Ratings Changes

SOLV has been the topic of several research analyst reports. Mizuho began coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock. Piper Sandler raised their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, Morgan Stanley raised their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Solventum currently has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Performance

NYSE:SOLV opened at $76.30 on Tuesday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company’s 50 day moving average is $71.28 and its 200-day moving average is $69.37.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.